Trial intelligence / Profile preview

Dronabinol in Functional Chest Pain

NCT02569073Phase 4Withdrawn

Sponsor
Temple University
Start
Jun 2017
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dronabinol in functional chest pain (FCP), sponsored by Temple University. Planned start Jun 2017; status: withdrawn.

02

Drugs

dronabinol
03

Conditions

functional chest pain (FCP)

Beyond the preview

Go deeper on NCT02569073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02569073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call